MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
With a market cap of 844.2M, MannKind(MNKD) trades at $2.74. The stock has a price-to-earnings ratio of 156.15.
On 2026-04-22, MannKind(MNKD) stock traded between a low of $2.66 and a high of $2.79. Shares are currently priced at $2.74, which is +3.0% above the low and -1.8% below the high.
MannKind(MNKD) shares are trading with a volume of 1.32M, against a daily average of 3.39M.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
MNKD News
MannKind Corporation (MNKD) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.